# Forrester Research share price today (Forrester Research, Inc., FORR)

> Forrester Research, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. FORR · Industrials · Consulting Services · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/forr

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from fewer quarters than usual
- Price: $9.57 (+34.2% in a year)
- Revenue (Jun 2026): $100 M (−10.2% on a year ago)
- Profit (Jun 2026): $15.3 M (+289.8% on a year ago)
- Operating margin: 5.5% (−1.2 points on a year ago)
- ROE: −94%, FY25
- ROIC: 2.4%, against a 8.0% cost of capital: −5.6 points
- Profit that came in as cash: 338%, last 3 years

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Forrester Research share price today? Forrester Research, Inc.'s share price was $9.57 at the close on 3 November 2026. That is 11.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between $5 and $13, and at that close it sat 59% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 2 weeks running. Over the last 1 year the share price moved −3% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Forrester Research pay? Forrester Research, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Forrester Research on? Forrester Research is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Forrester Research profitable? Forrester Research, Inc. earned $15.3 M of net profit in the Jun 2026 quarter, +289.8% on the same quarter a year earlier. The full FY25 year was a loss of $119 M. That is 15.2% of the quarter's revenue. The same quarter a year earlier earned $3.9 M. 7 of the last 12 reported quarters were loss-making. ## How much revenue does Forrester Research make, and is it growing? Forrester Research, Inc. reported $100 M of revenue in the Jun 2026 quarter, −10.2% on the same quarter a year earlier. Over 4 years it has grown −5.3% a year on average. The last full year, FY25, came in at $397 M. The last four reported quarters add to $381 M. FY25 revenue was $397 M, −8.2% on the year before. Recent pace: the last four quarters grew −7.4% on average, against −5.3% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −7.5%, against −8.3% a year over the last 8 quarters (stabilising). ## How much of every $100 of sales does Forrester Research keep? Forrester Research, Inc.'s operating margin was 5.5% in the Jun 2026 quarter, 1.2 percentage points lower than the same quarter a year ago. Across 5 years it has been between 2.3% and 7.9%. The latest quarter is within that range. Why the margin moved: operating margin changed −1.2 percentage points on the year while gross margin changed +0.9 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Forrester Research's profit turning into cash? Over the last 3 years, 338% of Forrester Research, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $21.1 M of operating cash against −$119 M of profit. After $3.0 M of spending on assets, $18.1 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Forrester Research's cash go? Forrester Research, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $11.9 M on assets over the last 3 years. Averaged over those years that is 1.0% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $11.9 M over the last 3 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is Forrester Research's P/E ratio, and how does it compare with its own history? Forrester Research, Inc. has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Forrester Research, Inc. at 0.5× its FY25 revenue of $397 M. The P/E comes back here once profit turns positive. ## Is the Forrester Research business getting better or worse? Forrester Research, Inc.'s business is getting worse. Revenue and profit growth are shrinking: revenue growth is −7.5% in the latest quarter, against −6.6% at its best in 12 quarters, with ROCE steady at 4.6%. This is based on 12 quarters of 3 measures, with some gaps. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does Forrester Research earn on its capital? Forrester Research, Inc. earned a ROE of −94% in FY25. Its return on capital used (ROIC) is 5.6 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −30.1% net margin and 0.98× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −30.1% net margin × 0.98× asset turnover × 3.19× leverage (assets divided by equity) ≈ −94.1% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 2.4% − 8.0% = −5.6 percentage points. The 8.0% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 2.4% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 6.9%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Forrester Research have too much debt? Forrester Research, Inc. has total debt of $64.0 M against shareholder equity of $122 M as of Jun 2026, so its debt is 0.53× its equity. Year by year, that ratio went from 0.75 in FY21 to 0.57 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Forrester Research shareholding pattern? 5.8% of Forrester Research, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 5.1 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Forrester Research from balance-sheet trouble? For Forrester Research, Inc., the Z-score is 1.44. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 1.44 is inside the danger zone, so the balance sheet is a real risk. ## How does Forrester Research rank in its industry? 34.8 out of 100, rank 9 of 13 in Consulting Services, with 64% of the evidence available. Forrester Research, Inc. scores 34.8 out of 100 against the 13 companies it is compared with in Consulting Services, ranking 9. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 11.1 + 5.8 + 11.5 + 6.4 = 34.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Forrester Research compared with? Forrester Research ranks 9 of 13 Consulting Services companies on the 4-Factor Sector Score, with 34.8 out of 100. 1. [Huron Consulting Group Inc.](https://www.sectoralpha.in/us/stocks/hurn) HURN · leader · Most evidence points up · 81% evidence 73.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.3/35 · Revenue 13.9% · Profit 9.5% · Operating margin change 0.2 points · 83% evidence Capital efficiency 15.3/25 · ROCE 16.1% · Operating margin 11.7% · 76% evidence Valuation 14.2/20 · P/E 11.9× · PEG 0.71 · 65% evidence Relative strength 19.5/20 · Lead over its industry 11.7% · Lead over S&P 500 29.3% · 1 year 19.6% · 100% evidence · 12 of 12 weeks ahead Exact sum: 24.3 + 15.3 + 14.2 + 19.5 = 73.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [SBC Medical Group Holdings Incorporated](https://www.sectoralpha.in/us/stocks/sbc) SBC · leader · Most evidence points up · 81% evidence 72.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.1/35 · Revenue -6.4% · Profit 44.1% · Operating margin change 4.9 points · 83% evidence Capital efficiency 17.4/25 · ROCE 19.9% · Operating margin 38.5% · 76% evidence Valuation 16.2/20 · P/E 6.4× · PEG 0.14 · 65% evidence Relative strength 18.9/20 · Lead over its industry 8.3% · Lead over S&P 500 25.4% · 1 year 65.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.1 + 17.4 + 16.2 + 18.9 = 72.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [FTI Consulting, Inc.](https://www.sectoralpha.in/us/stocks/fcn) FCN · turning · Evidence leans up · 81% evidence 55.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 7.1% · Profit 1.6% · Operating margin change -1.3 points · 83% evidence Capital efficiency 13.4/25 · ROCE 14% · Operating margin 9.2% · 76% evidence Valuation 11.8/20 · P/E 17.4× · PEG 1.06 · 65% evidence Relative strength 13.1/20 · Lead over its industry -3.1% · Lead over S&P 500 12.8% · 1 year 18.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 17.3 + 13.4 + 11.8 + 13.1 = 55.6 · What this means: Relative strength against the index is 12.8%, and revenue and profit growth are weak. 4. [Verisk Analytics, Inc.](https://www.sectoralpha.in/us/stocks/vrsk) VRSK · turning · Too little evidence to rank firmly · 56% evidence 54.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue n/a · Profit n/a · Operating margin change -0.8 points · 39% evidence Capital efficiency 20.8/25 · ROCE 41.7% · Operating margin 45.1% · 76% evidence Valuation 8.5/20 · P/E 26.6× · PEG n/a · 15% evidence Relative strength 4.5/20 · Lead over its industry -16.8% · Lead over S&P 500 -3.1% · 1 year -8.2% · 100% evidence · 3 of 12 weeks ahead Exact sum: 21.1 + 20.8 + 8.5 + 4.5 = 54.9 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [Equifax Inc.](https://www.sectoralpha.in/us/stocks/efx) EFX · turning · Evidence leans up · 85% evidence 52.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.8/35 · Revenue 10.9% · Profit 13.1% · Operating margin change 3.9 points · 95% evidence Capital efficiency 13.7/25 · ROCE 11.6% · Operating margin 21% · 76% evidence Valuation 9.5/20 · P/E 21.7× · PEG 1.27 · 65% evidence Relative strength 3.8/20 · Lead over its industry -17.3% · Lead over S&P 500 -3.6% · 1 year -9.6% · 100% evidence · 4 of 12 weeks ahead Exact sum: 25.8 + 13.7 + 9.5 + 3.8 = 52.8 · What this means: Earnings are strong; relative strength in its sector is -17.3% and the one-year return is -9.6%. 6. [CRA International, Inc.](https://www.sectoralpha.in/us/stocks/crai) CRAI · breaking out · Evidence leans up · 85% evidence 52.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 8.8% · Profit -12.5% · Operating margin change 1.9 points · 95% evidence Capital efficiency 18.5/25 · ROCE 30.2% · Operating margin 11.2% · 76% evidence Valuation 4.2/20 · P/E 19.3× · PEG 3.24 · 65% evidence Relative strength 9.2/20 · Lead over its industry -6.9% · Lead over S&P 500 8.1% · 1 year 8.3% · 100% evidence · 10 of 12 weeks ahead Exact sum: 20.3 + 18.5 + 4.2 + 9.2 = 52.2 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 7. [Booz Allen Hamilton Holding Corporation](https://www.sectoralpha.in/us/stocks/bah) BAH · breaking out · Evidence leans down · 85% evidence 48.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.9/35 · Revenue -6.2% · Profit -5.4% · Operating margin change -1 points · 95% evidence Capital efficiency 14.2/25 · ROCE 16.6% · Operating margin 8.8% · 76% evidence Valuation 15.2/20 · P/E 10.7× · PEG 0.24 · 65% evidence Relative strength 8.5/20 · Lead over its industry -10.3% · Lead over S&P 500 4.4% · 1 year -0.5% · 100% evidence · 7 of 12 weeks ahead Exact sum: 10.9 + 14.2 + 15.2 + 8.5 = 48.8 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 8. [ICF International, Inc.](https://www.sectoralpha.in/us/stocks/icfi) ICFI · leader · Evidence leans down · 81% evidence 44.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.3/35 · Revenue -7.9% · Profit -18.4% · Operating margin change 0 points · 83% evidence Capital efficiency 10.0/25 · ROCE 8.4% · Operating margin 8.4% · 76% evidence Valuation 9.7/20 · P/E 14.9× · PEG 1.42 · 65% evidence Relative strength 12.1/20 · Lead over its industry -0.3% · Lead over S&P 500 15.7% · 1 year 19.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 12.3 + 10 + 9.7 + 12.1 = 44.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. Forrester Research, Inc. this page FORR · losing its lead · Most evidence points down · 64% evidence 34.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.1/35 · Revenue -8% · Profit n/a · Operating margin change -1.2 points · 62% evidence Capital efficiency 5.8/25 · ROCE 1.8% · Operating margin 5.5% · 76% evidence Valuation 11.5/20 · P/E -3.8× · PEG n/a · 15% evidence Relative strength 6.4/20 · Lead over its industry -4.6% · Lead over S&P 500 9.8% · 1 year 27.3% · 100% evidence · 10 of 12 weeks ahead Exact sum: 11.1 + 5.8 + 11.5 + 6.4 = 34.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. Zi Yun Dong Fang Limited YLY · Too little evidence to rank firmly · 11% evidence 57.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/43.75 · Revenue n/a · Profit n/a · Operating margin change n/a · 0% evidence Capital efficiency 22.8/31.25 · ROCE 110.6% · Operating margin n/a · 46% evidence Valuation 12.5/25 · P/E n/a · PEG n/a · 0% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 21.9 + 22.8 + 12.5 = 57.2 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 11. [Etoiles Capital Group Co., Ltd](https://www.sectoralpha.in/us/stocks/efty) EFTY · Too little evidence to rank firmly · 19% evidence 39.9 out of 100 Growth Capital Valuation Relative
12. Enigmatig Limited EGG · Too little evidence to rank firmly · 19% evidence 38.1 out of 100 Growth Capital Valuation Relative
13. Resources Connection, Inc. RGP · Too little evidence to rank firmly · 47% evidence 27.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Consulting Services](https://www.sectoralpha.in/us/sectors/consulting-services), all 13 compared on one page. ## Which companies are close to Forrester Research in size? Forrester Research is the 11th largest of 11 Consulting Services companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Huron Consulting Group Inc., ICF International, Inc., CRA International, Inc., SBC Medical Group Holdings Incorporated, Roma Green Finance and Etoiles Capital Group Co. It is the smallest. ### Consulting Services companies close in size

1. [Huron Consulting Group Inc.](https://www.sectoralpha.in/us/stocks/hurn) $3 billion
2. [ICF International, Inc.](https://www.sectoralpha.in/us/stocks/icfi) $1.8 billion
3. [CRA International, Inc.](https://www.sectoralpha.in/us/stocks/crai) $1.2 billion
4. [SBC Medical Group Holdings Incorporated](https://www.sectoralpha.in/us/stocks/sbc) $536 million
5. [Roma Green Finance Limited](https://www.sectoralpha.in/us/stocks/roma) $390 million
6. [Etoiles Capital Group Co., Ltd](https://www.sectoralpha.in/us/stocks/efty) $302 million
7. Forrester Research, Inc. $182 million

[All 11 Consulting Services companies, largest first](https://www.sectoralpha.in/us/sectors/consulting-services#all-companies)

### Companies close in size in other industries

1. [Velo3D, Inc.](https://www.sectoralpha.in/us/stocks/velo) $211 million · Computer Hardware
2. [Korro Bio, Inc.](https://www.sectoralpha.in/us/stocks/krro) $211 million · Biotechnology
3. Forrester Research, Inc. $210 million
4. [First Capital, Inc.](https://www.sectoralpha.in/us/stocks/fcap) $209 million · Banks - Regional
5. [Bakkt, Inc.](https://www.sectoralpha.in/us/stocks/bkkt) $209 million · Software - Infrastructure

## What else do people ask about Forrester Research? ### What were Forrester Research's latest quarterly results? Forrester Research, Inc. reported revenue of $100 M and net profit of $15.3 M for the Jun 2026 quarter. Revenue fell 10.2% and profit rose 289.8% compared with a year earlier. Earnings per share were $0.78. The operating margin was 5.5%, 1.2 percentage points lower than a year earlier (as of 3 November 2026). ### What is Forrester Research's market cap? Forrester Research, Inc.'s market capitalisation is $182 M at a stock price of $9.57. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Forrester Research performing? Forrester Research, Inc.'s latest readings are below. In its latest quarter, revenue fell 10.2% and profit rose 289.8% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 2 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Forrester Research's stock price go up? This page does not forecast Forrester Research, Inc.'s stock price. What it shows instead: the stock price is $9.57. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Is Forrester Research's profit real cash? Yes, over the last 3 years, 338% of Forrester Research, Inc.'s reported profit came in as cash from operations. The latest year was lower at -18%, so the trend is worth watching. In FY25, operating cash was $21.1 M against reported profit of −$119 M. Most of that cash then goes into building new capacity. These are yearly figures (as of 3 November 2026). ### Where is Forrester Research in its business cycle? Forrester Research, Inc.'s FY25 operating margin was 2.3%, against a 5-year range of 2.3% to 7.9%: the low end of its own range, which is often where recoveries start. The latest quarter was 5.5%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Forrester Research story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Forrester Research a stock worth studying right now? What the numbers show: Forrester Research, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.